More than 100 federal lawsuits have been filed across the country as a result of consumers being killed or injured by the side-effects of the anti-coagulant Pradaxa, manufactured by the German company Boehringer Ingelheim. 
Those suits have now been consolidated in a "Multi-District Litigation" proceeding, and they have all been sent to a judge
Atrial fibrillation is a type of irregular heartbeat that can cause blood clots, heart attacks and strokes. For years, doctors have prescribed blood-thinners like Coumadin, also known as warfarin, to those who suffer from atrial fibrillation. The blood thinners prevent the clots from forming, and so prevent the heart attacks and strokes.
A few years ago a
More than 10 years ago during animal trials of the diabetes drug Actos, its manufacturer (Takeda International) learned that rats exposed to Actos developed more bladder tumors than rats exposed to a placebo. Takeda did not research the cause of increased rate of tumor formation, nor did it conduct further studies with human
Takeda International is a global pharmaceutical company headquartered in Japan. It’s top selling product, Actos, improves the body’s insulin use; while it also reduces blood sugar levels. In 1998 Takeda entered into a marketing partnership with Eli Lilly and Co. to push Actos in the United States and obtain FDA approval. Remarkably, one year
Four out of five ads in medical journals targeting doctors fail to follow FDA guidelines. Over half fail to quantify the risks. Dr. Deborah Korenstein, lead author of a recent study and Associate Professor of Medicine at Mount Sinai School of Medicine states:
Marketing research has consistently shown that journal advertising is the most profitable form of
Beyaz is Bayer Healthcare Phamaceuticals’ newest birth control pill. In its latest marketing ploy, Bayer enriched its Yaz product. The new pill includes levomefolate calcium, which is designed to increase folate levels in women to help prevent neural tube birth defects. Neural tube birth defects include spina bifida and encephalopathy. 
Prevention of birth defects is
In April, U.S. scientists reported that short term use of the popular diabetes drug, Actos (pioglitazone), posed no risk of bladder cancer, while use for more than two years was only weakly associated with an increased risk.
But last month a French study found diabetics who used Actos for longer than 12 months were exposed to a 40
Actos has become one of the most popular treatments for type 2 diabetes melli
tus. Now the FDA is warning of a link between Actos and bladder cancer. A recent study showed that the risk increases by 40% after 12 months on the drug. That risk is significant enough that the use of the drug has been suspended
The Food and Drug Administration approved Yaz and Yasmin based on research that Bayer provided saying that the drugs were safe. We’ve been saying all along that the research was suspect and that, in fact, the drug is more risky than other birth control pills with no added benefits. The danger, we said, was the
Darvon and Darvocet are names for a drug that has been prescribed for many years to manage pain. In 2009, its generic version alone — Propoxyphene — was prescribed more than 17 million times.
In November, the FDA determined that the drug can cause serious cardiac problems, including arrhythmias and heart attacks, and recommended that the drug be
